E670G PCSK9 polymorphism in HeFH & CAD with diabetes: is the bridge to personalized therapy within reach?

OBJECTIVE: To assess the distribution of PCSK9 E670G genetic polymorphism and PCSK9 levels in patients with Coronary Artery Disease (CAD) and Heterozygous Familial Hypercholesterolemia (HeFH), based on the presence of type 2 Diabetes Mellitus (T2DM). METHODS: The study included 201 patients with chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alieva, Rano, Shek, Aleksandr, Abdullaev, Alisher, Fozilov, Khurshid, Khoshimov, Shovkat, Abdullaeva, Guzal, Zakirova, Dariya, Kurbanova, Rano, Kan, Lilia, Kim, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Clinical Diabetes and Healthcare
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646404/
https://www.ncbi.nlm.nih.gov/pubmed/38028979
http://dx.doi.org/10.3389/fcdhc.2023.1277288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646404/
https://www.ncbi.nlm.nih.gov/pubmed/38028979
http://dx.doi.org/10.3389/fcdhc.2023.1277288

Ejemplares similares